Predictors of persistent avascular retina in retinopathy of prematurity treated with intravitreal ranibizumab.

چکیده

To identify predictive factors for persistent avascular retina (PAR) following primary intravitreal ranibizumab (IVR) monotherapy in retinopathy of prematurity (ROP). The medical records of 69 infants (128 eyes) with type 1 or aggressive ROP treated with IVR at a single center between July 2019 and…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• درمان های ضد VEGF